G(1)4 —
REGISTRATION OF LETTERS PATENT.
12. The revenue derived from this source amounted to $110.00 as against $259.00 in 1936. The decrease is due to fewer registrations.
Year Number of Registration patents fees Other fees Total fees 1937 8 $80.00 $30.00 $110.00 1936 21 $170.00 $89.00 $259.00TOTAL REVENUE AND EXPENDITURE.
13. The following are totals of revenue and expenditure for the department of the Official Receiver and Registrar of Trade Marks and Letters Patent for the years 1936 and 1937 respectively, (the expenditure including personal emoluments of officers in the Junior Clerical Service):-
Revenue Expenditure 1936 $70,034.92 $24,884.40 1937 $45,985.31 $21,270.10This shows a net profit of $24,715.21 for 1937 against a net profit of $45,150.52 for 1936 being a decrease of $20,435.31, due principally to there being no very large liquidations or bankruptcies in 1937.
L. R. ANDREWES,
Official Receiver and
Registrar of Trade Marks & Patents.
Hong Kong, 4th March, 1938.
- G (1) 4 —
REGISTRATION OF LETTERS PATENT.
12. The revenue derived from this source amounted to $110.00 as against $259.00 in 1936. The decrease is due to fewer registrations.
Year.
Number of Registration
patents.
fees.
Other fees. Total fees.
1937
8
$80.00
$30.00
$110.00
1936
21
$170.00
$89.00
$259.00
TOTAL REVENUE AND EXPENDITURE.
13. The following are totals of revenue and expenditure for the department of the Official Receiver and Registrar of Trade Marks and Letters Patent for the years 1936 and 1937 respectively, (the expenditure including personal emoluments ci officers in the Junior Clerical Service):-
Revenue,
Expenditure.
1936....
$70,034.92
$24,884.40
1937.
$45,985.31
$21,270.10
This shows a net profit of $24,715.21 for 1937 against a net profit of $45,150.52 for 1936 being a decrease of $20,435.31, due principally to there being no very large liquidations or bank- ruptcies in 1937.
L. R. ANDREWES,
Official Receiver and
Registrar of Trade Marks & Patents.
Hong Kong, 4th March, 1938.
No comments yet.
Private notes are available after approval.